Platelets, acting in part via P-selectin, mediate cytomegalovirus-induced microvascular dysfunction

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 307, Issue 12, 2014, Pages H1745-H1753

  Khoretonenko, Mikhail V ^a,b   Brunson, Jerry L ^a,b   Senchenkov, Evgeny ^a   Leskov, Igor L ^a   Marks, Christian R ^a   Stokes, Karen Y ^a,b  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b Louisiana State University School of Medicine Shreveport   (United States)

Author keywords

Arteriolar dilation; Hypercholesterolemia; Leukocyte adhesion; Microvasculature; Platelets

Indexed keywords

PADGEM PROTEIN; CHOLESTEROL;

ADHESION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIOLE; ARTICLE; BONE MARROW; CHOLESTEROL DIET; CONTROLLED STUDY; CYTOMEGALOVIRUS; ENDOTHELIAL DYSFUNCTION; INFLAMMATORY INFILTRATE; LEUKOCYTE; LEUKOCYTE ADHERENCE; MOUSE; NONHUMAN; THROMBOCYTE; VASCULAR DISEASE; VASODILATATION; ANIMAL; C57BL MOUSE; CELL ADHESION; CYTOMEGALOVIRUS INFECTION; DRUG EFFECTS; LIPID DIET; METABOLISM; MICROVASCULATURE; MUROMEGALOVIRUS; PATHOGENICITY; PATHOPHYSIOLOGY; PHYSIOLOGY; VIROLOGY;

ANIMALS; BLOOD PLATELETS; CELL ADHESION; CHOLESTEROL; CYTOMEGALOVIRUS INFECTIONS; DIET, HIGH-FAT; LEUKOCYTES; MICE; MICE, INBRED C57BL; MICROVESSELS; MUROMEGALOVIRUS; P-SELECTIN; VASODILATION;

EID: 84918842402     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00201.2014     Document Type: Article

References (47)

1. Aslam M, Anderson JL, Guglietti D, Cardwell D. CMV-induced neonatal thrombocytopenia: a case report and review of the literature. Am J Perinatol 24: 429-434, 2007.
2. Assinger A, Kral J, Yaiw KC, Schrottmaier W, Kurzejamska E, Wang Y, Mohammad AA, Religa P, Rahbar A, Schabbauer G, Butler LM, Soderberg-Naucler C. Human cytomegalovirus-platelet interaction triggers Toll-like receptor 2-dependent proinflammatory and proangiogenic responses. Arterioscler Thromb Vasc Biol 34: 801-809, 2014.
3. Atzmony L, Halutz O, Avidor B, Finn T, Zimmerman O, Steinvil A, Zeltser D, Giladi M, Justo D. Incidence of cytomegalovirus-associated thrombosis and its risk factors: a case-control study. Thromb Res 126: e439-e443, 2010.
4. Bentz GL, Jarquin-Pardo M, Chan G, Smith MS, Sinzger C, Yurochko AD. Human cytomegalovirus (HCMV) infection of endothelial cells promotes naive monocyte extravasation and transfer of productive virus to enhance hematogenous dissemination of HCMV. J Virol 80: 11539-11555, 2006.
5. Blum A, Giladi M, Weinberg M, Kaplan G, Pasternack H, Laniado S, Miller H. High anti-cytomegalovirus (CMV) IgG antibody titer is associated with coronary artery disease and may predict post-coronary balloon angioplasty restenosis. Am J Cardiol 81: 866-868, 1998.
6. Burnett MS, Gaydos CA, Madico GE, Glad SM, Paigen B, Quinn TC, Epstein SE. Atherosclerosis in apoE knockout mice infected with multiple pathogens. J Infect Dis 183: 226-231, 2001.
7. Burns LJ, Pooley JC, Walsh DJ, Vercellotti GM, Weber ML, Kovacs A. Intercellular adhesion molecule-1 expression in endothelial cells is activated by cytomegalovirus immediate early proteins. Transplantation 67: 137-144, 1999.
8. Cai H, Harrison DG. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res 87: 840-844, 2000.
9. Chiu B, Viira E, Tucker W, Fong IW. Chlamydia pneumoniae, cytomegalovirus, and herpes simplex virus in atherosclerosis of the carotid artery. Circulation 96: 2144-2148, 1997.
10. Compton T, Kurt-Jones EA, Boehme KW, Belko J, Latz E, Golenbock DT, Finberg RW. Human cytomegalovirus activates inflammatory cytokine responses via CD14 and Toll-like receptor 2. J Virol 77: 4588-4596, 2003.
11. Cooper D, Chitman KD, Williams MC, Granger DN. Time-dependent platelet-vessel wall interactions induced by intestinal ischemia-reperfusion. Am J Physiol Gastrointest Liver Physiol 284: G1027-G1033, 2003.
12. Craigen JL, Yong KL, Jordan NJ, MacCormac LP, Westwick J, Akbar AN, Grundy JE. Human cytomegalovirus infection up-regulates interleukin-8 gene expression and stimulates neutrophil transendothelial migration. Immunology 92: 138-145, 1997.
13. Delbos V, Abgueguen P, Chennebault JM, Fanello S, Pichard E. Acute cytomegalovirus infection and venous thrombosis: role of antiphospholipid antibodies. J Infect 54: e47-50, 2007.
14. Dengler TJ, Raftery MJ, Werle M, Zimmermann R, Schonrich G. Cytomegalovirus infection of vascular cells induces expression of proinflammatory adhesion molecules by paracrine action of secreted interleukin-1+. Transplantation 69: 1160-1168, 2000.
15. Epstein SE, Zhu J, Najafi AH, Burnett MS. Insights into the role of infection in atherogenesis and in plaque rupture. Circulation 119: 3133-3141, 2009.
16. Espinola-Klein C, Rupprecht HJ, Blankenberg S, Bickel C, Kopp H, Victor A, Hafner G, Prellwitz W, Schlumberger W, Meyer J. Impact of infectious burden on progression of carotid atherosclerosis. Stroke 33: 2581-2586, 2002.
17. Freeman RB Jr. The "indirect" effects of cytomegalovirus infection. Am J Transplant 9: 2453-2458, 2009.
18. Grahame-Clarke C, Chan NN, Andrew D, Ridgway GL, Betteridge DJ, Emery V, Colhoun HM, Vallance P. Human cytomegalovirus seropositivity is associated with impaired vascular function. Circulation 108: 678-683, 2003.
19. Grattan MT, Moreno-Cabral CE, Starnes VA, Oyer PE, Stinson EB, Shumway NE. Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis. JAMA 261: 3561-3566, 1989.
20. Grundy JE, Lawson KM, MacCormac LP, Fletcher JM, Yong KL. Cytomegalovirus-infected endothelial cells recruit neutrophils by the secretion of C-X-C chemokines and transmit virus by direct neutrophilendothelial cell contact and during neutrophil transendothelial migration. J Infect Dis 177: 1465-1474, 1998.
21. Hsich E, Zhou YF, Paigen B, Johnson TM, Burnett MS, Epstein SE. Cytomegalovirus infection increases development of atherosclerosis in apolipoprotein-E knockout mice. Atherosclerosis 156: 23-28, 2001.
22. Khoretonenko MV, Leskov IL, Jennings SR, Yurochko AD, Stokes KY. Cytomegalovirus infection leads to microvascular dysfunction and exacerbates hypercholesterolemia-induced responses. Am J Pathol 177: 2134-2144, 2010.
23. Kim MH, Granger DN, Harris NR. Mediators of CD18/P-selectindependent constriction of venule-paired arterioles in hypercholesterolemia. Microvasc Res 73: 150-155, 2007.
24. Kupatt C, Wichels R, Horstkotte J, Krombach F, Habazettl H, Boekstegers P. Molecular mechanisms of platelet-mediated leukocyte recruitment during myocardial reperfusion. J Leukoc Biol 72: 455-461, 2002.
25. Kurose I, Argenbright LW, Anderson DC, Tolley J, Miyasaka M, Harris N, Granger DN. Reperfusion-induced leukocyte adhesion and vascular protein leakage in normal and hypercholesterolemic rats. Am J Physiol Heart Circ Physiol 273: H854-H860, 1997.
26. Kurose I, Wolf R, Cerwinka W, Granger DN. Microvascular responses to ischemia/reperfusion in normotensive and hypertensive rats. Hypertension 34: 212-216, 1999.
27. Ladd AM, Goyal R, Rosainz L, Baiocco P, DiFabrizio L. Pulmonary embolism and portal vein thrombosis in an immunocompetent adolescent with acute cytomegalovirus hepatitis. J Thromb Thrombolysis 28: 496-499, 2009.
28. Landmesser U, Hornig B, Drexler H. Endothelial function: a critical determinant in atherosclerosis? Circulation 109: II27-II33, 2004.
29. Panes J, Kurose I, Rodriguez-Vaca D, Anderson DC, Miyasaka M, Tso P, Granger DN. Diabetes exacerbates inflammatory responses to ischemia-reperfusion. Circulation 93: 161-167, 1996.
30. Puccetti L, Sawamura T, Pasqui AL, Pastorelli M, Auteri A, Bruni F. Atorvastatin reduces platelet-oxidized-LDL receptor expression in hypercholesterolaemic patients. Eur J Clin Invest 35: 47-51, 2005.
31. Rahbar A, Soderberg-Naucler C. Human cytomegalovirus infection of endothelial cells triggers platelet adhesion and aggregation. J Virol 79: 2211-2220, 2005.
32. Sanguigni V, Pignatelli P, Lenti L, Ferro D, Bellia A, Carnevale R, Tesauro M, Sorge R, Lauro R, Violi F. Short-term treatment with atorvastatin reduces platelet CD40 ligand and thrombin generation in hypercholesterolemic patients. Circulation 111: 412-419, 2005.
33. Senchenkov E, Khoretonenko MV, Leskov IL, Ostanin DV, Stokes KY. P-selectin mediates the microvascular dysfunction associated with persistent cytomegalovirus infection in normocholesterolemic and hypercholesterolemic mice. Microcirculation 18: 452-462, 2011.
34. Shahgasempour S, Woodroffe SB, Garnett HM. Alterations in the expression of ELAM-1, ICAM-1 and VCAM-1 after in vitro infection of endothelial cells with a clinical isolate of human cytomegalovirus. Microbiol Immunol 41: 121-129, 1997.
35. Smyth SS, McEver RP, Weyrich AS, Morrell CN, Hoffman MR, Arepally GM, French PA, Dauerman HL, Becker RC. Platelet functions beyond hemostasis. J Thromb Haemost 7: 1759-1766, 2009.
36. Span AH, Mullers W, Miltenburg AM, Bruggeman CA. Cytomegalovirus induced PMN adherence in relation to an ELAM-1 antigen present on infected endothelial cell monolayers. Immunology 72: 355-360, 1991.
37. Stokes K, Granger DN. The microcirculation: a motor for the systemic inflammatory response and large vessel disease induced by hypercholesterolemia? J Physiol 562: 647-653, 2005.
38. Stokes KY, Calahan L, Russell JM, Gurwara S, Granger DN. Role of platelets in hypercholesterolemia-induced leukocyte recruitment and arteriolar dysfunction. Microcirculation 13: 377-388, 2006.
39. Stokes KY, Dugas TR, Tang Y, Garg H, Guidry E, Bryan NS. Dietary nitrite prevents hypercholesterolemic microvascular inflammation and reverses endothelial dysfunction. Am J Physiol Heart Circ Physiol 296: H1281-H1288, 2009.
40. Stokes KY, Granger DN. Platelets: a critical link between inflammation and microvascular dysfunction. J Physiol 590: 1023-1034, 2012.
41. Tailor A, Granger DN. Hypercholesterolemia promotes P-selectin-dependent platelet-endothelial cell adhesion in postcapillary venules. Arterioscler Thromb Vasc Biol 23: 675-680, 2003.
42. Tomita Y, Sachs DH, Sykes M. Myelosuppressive conditioning is required to achieve engraftment of pluripotent stem cells contained in moderate doses of syngeneic bone marrow. Blood 83: 939-948, 1994.
43. Vliegen I, Duijvestijn A, Grauls G, Herngreen S, Bruggeman C, Stassen F. Cytomegalovirus infection aggravates atherogenesis in apoE knockout mice by both local and systemic immune activation. Microbes Infect 6: 17-24, 2004.
44. Vliegen I, Stassen F, Grauls G, Blok R, Bruggeman C. MCMV infection increases early T-lymphocyte influx in atherosclerotic lesions in apoE knockout mice. J Clin Virol 25, Suppl 2: S159-S171, 2002.
45. Weis M, Kledal TN, Lin KY, Panchal SN, Gao SZ, Valantine HA, Mocarski ES, Cooke JP. Cytomegalovirus infection impairs the nitric oxide synthase pathway: role of asymmetric dimethylarginine in transplant arteriosclerosis. Circulation 109: 500-505, 2004.
46. Yaari S, Koslowsky B, Wolf D, Chajek-Shaul T, Hershcovici T. CMV-related thrombocytopenia treated with foscarnet: a case series and review of the literature. Platelets 21: 490-495, 2010.
47. Yi L, Wang DX, Feng ZJ. Detection of human cytomegalovirus in atherosclerotic carotid arteries in humans. J Formos Med Assoc 107: 774-781, 2008.